A Prospective, Randomized, Parallel, Three-arm, Open-label, Clinical Trial to Evaluate the Immunological Non-interference of Measles and Rubella Vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd. With Yellow Fever Vaccine Administered to Bangladeshi Healthy Infants Aged 9-12 Months
Latest Information Update: 13 Feb 2025
At a glance
- Drugs Measles mumps and rubella virus vaccine (Primary)
- Indications Measles; Rubella; Yellow fever
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 13 Feb 2025 New trial record